These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1370706)

  • 1. Solubilization, purification, and functional reconstitution of 5-hydroxytryptamine3 receptors from N1E-115 neuroblastoma cells.
    Lummis SC; Martin IL
    Mol Pharmacol; 1992 Jan; 41(1):18-23. PubMed ID: 1370706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
    Hoyer D; Neijt HC
    Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of 5-hydroxytryptamine3 receptors from porcine brain.
    Fletcher S; Barnes NM
    Br J Pharmacol; 1997 Oct; 122(4):655-62. PubMed ID: 9375961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical analysis of solubilized angiotensin II receptors from murine neuroblastoma N1E-115 cells by covalent cross-linking and affinity purification.
    Siemens IR; Adler HJ; Addya K; Mah SJ; Fluharty SJ
    Mol Pharmacol; 1991 Nov; 40(5):717-26. PubMed ID: 1944241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular properties of 5-hydroxytryptamine3 receptor-type binding sites purified from NG108-15 cells.
    Boess FG; Lummis SC; Martin IL
    J Neurochem; 1992 Nov; 59(5):1692-701. PubMed ID: 1402914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
    Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
    Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of [3H]meta-chlorophenylbiguanide binding to 5-HT3 receptors in N1E-115 neuroblastoma cells.
    Lummis SC; Sepúlveda MI; Kilpatrick GJ; Baker J
    Eur J Pharmacol; 1993 Oct; 243(1):7-11. PubMed ID: 8253126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
    Vilner BJ; John CS; Bowen WD
    Cancer Res; 1995 Jan; 55(2):408-13. PubMed ID: 7812973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of 5-HT3 receptors in intact N1E-115 neuroblastoma cells.
    Lummis SC; Kilpatrick GJ; Martin IL
    Eur J Pharmacol; 1990 Sep; 189(2-3):223-7. PubMed ID: 2253704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of detergents on ligand binding and translocation activities of solubilized/reconstituted nucleoside transporters.
    Hammond JR; Zarenda M
    Arch Biochem Biophys; 1996 Aug; 332(2):313-22. PubMed ID: 8806740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanol potentiation of 5-hydroxytryptamine3 receptor-mediated ion current in neuroblastoma cells and isolated adult mammalian neurons.
    Lovinger DM; White G
    Mol Pharmacol; 1991 Aug; 40(2):263-70. PubMed ID: 1715016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubilization and characterization of a guanine nucleotide-sensitive form of the calcitonin gene-related peptide receptor.
    Chatterjee TK; Moy JA; Cai JJ; Lee HC; Fisher RA
    Mol Pharmacol; 1993 Feb; 43(2):167-75. PubMed ID: 8381507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lipids in receptor mediated signal transduction.
    Banerjee P
    Indian J Biochem Biophys; 1993 Dec; 30(6):358-69. PubMed ID: 8005619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of YM060, a potent and selective 5-hydroxytryptamine3 receptor antagonist, in rabbit nodose ganglion and N1E-115 neuroblastoma cells.
    Ito H; Hidaka K; Miyata K; Kamato T; Nishida A; Honda K
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1127-32. PubMed ID: 1469624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
    McKinney M; Stenstrom S; Richelson E
    Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation.
    McKinney M; Stenstrom S; Richelson E
    Mol Pharmacol; 1984 Sep; 26(2):156-63. PubMed ID: 6148690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin receptor-mediated activation of adenylate cyclase in the neuroblastoma NCB.20: a novel 5-hydroxytryptamine receptor.
    Conner DA; Mansour TE
    Mol Pharmacol; 1990 May; 37(5):742-51. PubMed ID: 2338946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity purification of angiotensin type 2 receptors from N1E-115 cells: evidence for agonist-induced formation of multimeric complexes.
    Siemens IR; Yee DK; Reagan LP; Fluharty SJ
    J Neurochem; 1994 Jan; 62(1):257-64. PubMed ID: 8263526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT3 receptors in NG108-15 neuroblastoma x glioma cells: effect of the novel agonist 1-(m-chlorophenyl)-biguanide.
    Boess FG; Sepúlveda MI; Lummis SC; Martin IL
    Neuropharmacology; 1992 Jun; 31(6):561-4. PubMed ID: 1407396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubilisation of the 5-hydroxytryptamine3 receptor from pooled rat cortical and hippocampal membranes.
    McKernan RM; Quirk K; Jackson RG; Ragan CI
    J Neurochem; 1990 Mar; 54(3):924-30. PubMed ID: 2303819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.